Overall Technical outlook

Price Summary

The stock of GlaxoSmithKline Pharmaceuticals Limited experienced a -2.63% crash, showcasing a lousy market performance.
GlaxoSmithKline Pharmaceuticals Limited's stock opened at 2845.0 on 2025-09-05, surged to 2849.7, hit a low of 2755.0, and closed up -2.63% at 2770.3, with 64292 shares traded.
In the 52-week period, the stock's peak price is 3466.2, and the lowest price recorded is 1956.2.
4 analysts predict that the future price of GLAXO will be in the range of 2600.0 to 3500.0, with a mean expected price of about 3094.75.

Technicals

Support and Resistance: The current price of 2770.3 is supported at 2759.9, with resistance at 2906.8. This suggests that the price for GLAXO might remain between these levels, where 2759.9 acts as a floor and 2906.8 as a ceiling in the market.
GLAXO supportResistance 2df729
Support/Resistance for GLAXO


Aroon: The AROON is currently in a neutral position, offering no clear indication of movement up or down. This suggests that the market may be experiencing a period of equilibrium, with no strong trend in play.
GLAXO aroon 2df729
Aroon chart for GlaxoSmithKline Pharmaceuticals Limited


Bol. Bands: The BOLL BANDS is currently in a neutral position, offering no clear indication of movement up or down. This suggests that the market may be experiencing a period of equilibrium, with no strong trend in play.
GLAXO bbands 2df729
Bolinger Bands chart for GlaxoSmithKline Pharmaceuticals Limited


Parabolic SAR: The PSAR for GLAXO maintains its bullish outlook, setting a strong support level that could underpin further gains. This suggests that the market is likely to continue its upward trajectory, with the established support providing a safety net for ongoing bullish momentum.
GLAXO psar 2df729
Parabolic Stop and Reverse chart for GlaxoSmithKline Pharmaceuticals Limited


Stochastic: The STOCHASTIC is currently neutral, showing no clear bias toward an upward or downward trend. This suggests that the market may be in a phase of indecision or consolidation.
GLAXO stoch 2df729
Stochastic chart for GlaxoSmithKline Pharmaceuticals Limited


Tripple Moving Agerage: The Tripple MOVING AVG is showing a neutral stance, with no definitive indication of an upward or downward trend for GLAXO. This neutral position suggests a period of indecision in the market, making it difficult to predict the next move.
GLAXO trippleSMA 2df729
Tripple SMA chart for GlaxoSmithKline Pharmaceuticals Limited


When assessing a company's technical performance, such as stock price fluctuations and trading volume, it is crucial to first examine its fundamentals. These fundamentals include financial health, profitability, and growth potential. Additionally, understanding the industry's dynamics, including competitive pressures and market trends, is key to contextualizing the company's performance. By integrating these factors, a more comprehensive and meaningful analysis can be conducted, leading to more informed investment decisions.